Browse

The French drugmaker has agreed to acquire an experimental tablet from Edgewise Therapeutics that some bullish analysts say could eventually hit peak sales of over $2 billion.

The FDA has missed a self-imposed deadline to ban the use of electrical shock devices in people with intellectual disabilities.

We've been asking Medicare for weeks about the cost of giving seniors $50 obesity drugs.